The potential mechanism responsible for these differences may involve a switch in the release of immunostimulatory danger/damage-associated molecular patterns (DAMPs) (e.g., ATP and reduced HMGB1 [high mobility group box 1]) to immune-suppressive DAMPs (e.g., oxidized HMGB1 or PGE2 [prostaglandin E2]) [198, 199]
In such a case, the bond is isomerized by a specific enoyl-CoA isomerase and oxidation continues
ES2 is a senolytic peptide that targets FOXO4 CR3 but exhibits relatively poorer selectivity for senescent cells compared to FOXO4-DRI 25 (Table S1)
Having cagrilintide at a stable low dose during this transition is manageable for most researchers
In recent years, interest in the use of natural bioactive compounds to mitigate skin aging has increased, reflecting the global shift toward safer, sustainable, and health-conscious skincare solutions